Updated
Updated · New Scientist · Jun 17
Xu Team Launches 1-Hour Stroke Cooling Trial After 32-Patient Study Fell Short
Updated
Updated · New Scientist · Jun 17

Xu Team Launches 1-Hour Stroke Cooling Trial After 32-Patient Study Fell Short

3 articles · Updated · New Scientist · Jun 17

Summary

  • A follow-up clinical trial will test whether infusing promethazine and chlorpromazine over 1 hour can cool stroke patients fast enough to limit brain damage.
  • In a 32-patient phase I study, the drug pair was safe but lowered body temperature by only 0.3°C over 12 hours and did not reduce stroke injury alongside standard clot-removal treatment.
  • Animal results were stronger: mice and rhesus monkeys showed lower core temperatures, suppressed glucose metabolism and less brain damage after induced strokes, while treated monkeys also used their limbs better.
  • Physical cooling methods such as blankets, ice packs and helmets have largely failed in stroke because they trigger discomfort and shivering, making drug-induced hypothermia a more practical route if faster dosing works.

Insights

This 'hibernation' drug for stroke was safe but ineffective in its first human trial. Can a faster infusion really unlock its potential?
A similar drug cocktail was abandoned decades ago for being too dangerous. How is this new stroke therapy any different?

Pharmacological Cooling in Stroke: Insights from the 2026 Beijing Study and the Path to Clinical Implementation

Overview

Scientists at the Beijing Institute for Brain Disorders are leading research into a new drug-induced hypothermia approach for treating acute ischemic stroke. This method aims to protect brain tissue by reducing metabolic demand and inflammation, which helps limit the extent of injury after a stroke. The urgent need for effective neuroprotective strategies drives this work, as current treatments are limited. By using pharmacological agents to control cooling, the team hopes to create a crucial window to preserve neurological function. Their ongoing efforts could pave the way for better emergency care in stroke and other critical conditions.

...